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Summary
Transport of chloride through the cystic fibrosis transmem-
brane conductance regulator (CFTR) channel is a key step in
regulating fluid secretion in vertebrates [1, 2]. Loss of CFTR
function leads to cystic fibrosis [1, 3, 4], a disease that
affects the lungs, pancreas, liver, intestine, and vas defer-
ens. Conversely, uncontrolled activation of the channel
leads to increased fluid secretion and plays a major role in
several diseases and conditions including cholera [5, 6]
and other secretory diarrheas [7] as well as polycystic
kidney disease [8–10]. Understanding how CFTR activity is
regulated in vivo has been limited by the lack of a genetic
model. Here, we used a forward genetic approach in zebra-
fish to uncover CFTR regulators. We report the identifica-
tion, isolation, and characterization of a mutation in the
zebrafish cse1l gene that leads to the sudden and dramatic
expansion of the gut tube. We show that this phenotype
results from a rapid accumulation of fluid due to the uncon-
trolled activation of the CFTR channel. Analyses in zebrafish
larvae and mammalian cells indicate that Cse1l is a negative
regulator of CFTR-dependent fluid secretion. This work
demonstrates the importance of fluid homeostasis in devel-
opment and establishes the zebrafish as a much-needed
model system to study CFTR regulation in vivo.
Results and Discussion
Following a genetic screen designed to identify mutants with
defects in gut, liver, or pancreas organogenesis [11], we iden-
tified a recessive mutation, s866 (22.4% penetrance, n = 548),
which causes a striking gut phenotype. In s866 mutants,
internal organs appear to develop normally until 96–100 hr
postfertilization (hpf), at which time the gut tube undergoes
a process of expansion that results in a dramatically enlarged,
fluid-filled tube (Figure 1). We named this mutant baobab
(bao), after the African tree that accumulates water in its trunk.
Using confocal microscopy, we observed that baos866mutants
develop a flat epithelium (devoid of folds) lining the lumen of*Correspondence: m.bagnat@cellbio.duke.edu (M.B.), didier.stainier@ucsf.
edu (D.Y.R.S.)this enlarged intestinal tube (Figures 1A–1E). Occasionally,
delaminating cells were observed. However, baos866 mutants
still exhibit gut peristalsis, and the intestinal cells retain apical
membrane polarity, cadherin localization, tight junctions, and
basal laminin deposition (data not shown). Using transmission
electron microscopy, we observed a dramatic reduction in
cell height and microvilli length in baos866 mutant enterocytes
(Figures 1D and 1E). Nevertheless, baos866mutant enterocytes
retain expression and localization of the absorptive cell
marker 4e8 [12] (see Figure S1A available online). Although
all delaminating cells in baos866 mutants appeared to undergo
apoptosis, we did not observe a significant increase in
apoptosis inmutants compared towild-type (WT) (Figure S1B).
baos866 mutants also exhibit exocrine pancreas degeneration
and liver growth arrest after 96 hpf (Figure S1C).
To define the events leading to gut lumen expansion in
baos866 mutants, we first imaged the process from 96 to
120 hpf in larvae expressing histone 2A:GFP [13] using selec-
tive plane illumination microscopy [14]. This approach allowed
us to visualize the shape and size of the gut tube and follow cell
divisions. In WT larvae, the gut showed only a relatively small
(46%) and steady increase in tube diameter between 96 and
120 hpf (Figure 1H). Gut tube growth in WT was mostly due
to cell divisions, increased folding of the epithelium, and an
increase in cell height associated with enterocyte polarization
(see also Figures 1B and 1C) but not to changes in luminal
volume. In contrast, lumen expansion in the mutant was
dramatic (511%) and rapid, taking place in approximately
200 min, and without cell division (Figures 1F and 1G).
Next, we investigated the causes of gut lumen expansion in
baos866mutants. At the tissue level, this phenotype is reminis-
cent of what occurs in the gut of mice exposed to cholera toxin
[5], where the lumen is greatly enlarged by the CFTR-depen-
dent accumulation of fluid [9].CFTR (cystic fibrosis transmem-
brane conductance regulator) is a vertebrate-specific gene [1].
ZebrafishCftr shows 55% identity and 75%similarity to human
CFTR and is highly expressed in the gut by 4 days postfertiliza-
tion (see below and A.N. and M.B., unpublished data). To test
whether lumen expansion in baos866 mutants is CFTR depen-
dent, we treated WT and mutant larvae with CFTR inhibitors
from 72 to 120 hpf. Various CFTR inhibitors (glibenclamide,
CFTR172, and T08) effectively reduced the appearance of
severely enlarged guts in baos866 mutants (84% reduction for
5 mM T08, a CFTR172 analog [10]; n = 1017 in total, 242
mutants) (Figure 2A). In addition, treatment of baos866mutants
with the CFTR inhibitor T08 significantly increased enterocyte
height and microvilli length to levels close to WT (Figure S4).
Although the CFTR inhibitors blocked lumen expansion, they
did not prevent cell delamination, suggesting that cell delami-
nation/apoptosis and lumen expansion are two separable
phenotypes.
We next investigated the effects of CFTR activation. Soaking
120 hpf WT larvae in water containing a specific CFTR
activator [15] (15 mMCFTR-Act9) led to a robust and reversible
accumulation of fluid, resulting in a dramatic expansion of the
gut lumen and the flattening of enterocytes in half of the larvae
(50.8%, n = 360) (Figure 2Ba; Figure S2). This response had
kinetics and appearance (i.e., reduction in cell height and
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Figure 1. baos866 Mutants Undergo a Dramatic and Rapid Expansion of the Gut Lumen between 96 and 120 Hours Postfertilization
(A) Bright-field image of 120 hr postfertilization (hpf) wild-type (WT) and baos866 mutant larvae. Arrows point to the edges of the gut lumen.
(B and C) Confocal images of cross-sections of 120 hpfWT (B) and baos866mutant (C) larvae. The arrow in (C) points to a delaminating cell. Red is F-actin and
blue is DAPI; sb indicates swim bladder. Scale bars represent 50 mm.
(D and E) Dramatic shortening of microvilli (arrows) in baos866 mutant enterocytes observed by transmission electron microscopy at 120 hpf. Inset in (E)
shows remnants of apoptotic cells found in the lumen. GC indicates goblet cell. Scale bars represent 10 mm.
(F–I) Rapid expansion of the gut lumen in baos866 mutants expressing histone 2A:GFP.
(F) Still images (lateral views) from a baos866mutant selective plane illumination microscopy (SPIM) recording between 96 and 120 hpf showing first and last
frames.
(G and H) Kymographs from baos866 mutant (G) and WT (H) gut. Lumen expansion in the mutant occurred inw200 min; no cell division was observed.
(I) Still images (lateral views) from the baos866 mutant SPIM recording corresponding to the kymograph shown in (G).
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1841microvilli length) similar to those observed upon lumen expan-
sion in baos866 mutants but did not cause cell delamination
(Figure 2Bb; Figure S4). Altogether, our data indicate that the
increase in lumen size observed in baos866 mutants results
from the uncontrolled, CFTR-dependent accumulation of fluid
in the gut lumen. Because the baos866 mutation is recessive, it
follows that Bao is a negative regulator of CFTR-dependent
fluid secretion.
Because CFTR is regulated at multiple levels, including tran-
scriptional and posttranscriptional stages, it is possible that
the increased CFTR activity observed in baos866 mutants is
due to increased expression and/or differences in subcellular
localization of the channel. To investigate these possibilities,
we raised an antibody against zebrafish Cftr. In western blots,
the antibody recognized a protein of approximately 190 kDa
(Figure S3A). Importantly, the signal was dramatically reduced
in extracts prepared from larvae injected with an antisensemorpholino against Cftr compared to uninjected controls
(Figure S3A), indicating that the antibody recognizes CFTR
specifically. In transverse sections, the antibody stained the
apical surface of gut epithelial cells (Figure S3B). Western
blot and immunohistological analyses revealed that Cftr
protein levels and localization were not significantly different
in baos866 mutants compared to WT (Figure 2C). These data
suggest that Bao regulates CFTR-dependent fluid secretion
by controlling CFTR activity and rule out transcriptional regu-
lation, changes in CFTR steady-state levels, or subcellular
distribution. However, we cannot exclude the possibility that
differences in CFTR recycling [16], which would be very diffi-
cult to discern in vivo, also contribute to the increase in
CFTR activity observed in baos866 mutants.
To gain molecular insight into the cellular processes
controlled by the Bao protein, we undertook a positional
cloning project to isolate the corresponding gene. Using
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Figure 2. Lumen Expansion in baos866 Mutants Results from Increased CFTR-Dependent Fluid Secretion
(A) Inhibition of CFTR blocks lumen expansion in baos866 mutants.
(Aa) Bright-field images of WT and baos866 mutants incubated with DMSO (0.1%) or the CFTR inhibitor T08 (5 mM) from 72 to 120 hpf. Arrows point to the
edges of the gut lumen.
(Ab) Confocal images of cross-sections of 144 hpf control and T08-treated baos866mutants. Arrowheads point to delaminating cells. Red is F-actin and blue
is DAPI. Scale bars represent 50 mm.
(Ac) Quantification of the gut phenotype in control and T08-treated baos866mutants. Larvae were placed in three phenotypic categories (no phenotype, mild
phenotype, or severe phenotype) and then genotyped.
(B) Activation of CFTR in WT phenocopies the gut lumen expansion defect of baos866 mutants.
(Ba) Bright-field image of 144 hpf WT larvae treated with DMSO (0.15%) or CFTR-Act9 (15 mM). Arrows point to the edges of the gut lumen.
(Bb) Confocal images of cross-sections of 144 hpf control and CFTR-Act9-treated WT larvae. Red is F-actin and blue is DAPI. Scale bars represent 20 mm.
(C) Cftr expression and localization is not affected in baos866 mutants compared to WT.
(Ca) Immunoblot of 120 hpf WT and baos866 mutants probed against Cftr and b-tubulin.
(Cb) Confocal images of wholemounts of 120 hpfWT (top) and baos866mutant (bottom) stained for Cftr. Arrows point to the apical surface of the gut. Anterior
is to the right. Scale bars represent 50 mm.
Current Biology Vol 20 No 20
1842standard genetic mapping techniques, we defined a critical
genomic interval on chromosome 12 containing only two
genes, chromosome segregation 1-like (cse1l) and protein
tyrosine phosphatase receptor gamma (ptprg) (Figure 3A).
Next, we isolated cDNAs from WT and mutant larvae for both
genes. Sequencing of these cDNAs revealed the absence of
exon 16 in the middle of the cse1l transcript leading to a pre-
dicted premature stop codon in the next exon (Figures 3B
and 3C). Nomutations were found in the ptprg cDNA. Genomic
DNA sequencing revealed a T-to-A mutation upstream of the
exon 16 splice acceptor site (Figure 3B). We confirmed the
aberrant splicing of exon 16 in the mutant by reversetranscriptase PCR on pools of RNA made from baos866
mutants and WT siblings (Figure 3C). Cse1l was depleted in
extracts prepared from baos866 mutants compared to WT
siblings as judged by immunoblots using antibodies against
the N terminus of human CSE1L (Figure 3Da). However, we
could not unequivocally detect the predicted truncated form
of the protein in extractsmade from baos866mutants as a result
of the presence of a cross-reacting protein of the same size
(asterisk in Figure 3Da). To determine whether the mutant
cDNA produces a truncated protein, we transfected HEK293
cells and performed an immunoblot analysis. The mutant
cDNA produced a polypeptide of approximately 60 kDa, in
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Figure 3. Isolation of the bao Gene
(A) Positional cloning of bao. The number of recombinants (rec.) for each marker is shown.
(B) Sequencing of genomic DNA from +/+, 2/2, and +/2 larvae revealed a T-to-A mutation (arrow) upstream of the exon 16 splice acceptor site.
(C) Reverse transcriptase PCR on pools of RNAmade fromWT and baos866mutants demonstrates defective splicing of exon 16 in baos866mutants leading to
a premature stop codon in exon 17.
(Da) Cse1l is depleted in baos866 mutants. The asterisk marks the position of a cross-reacting protein band.
(Db) The baos866 mutation produces a truncated protein that can be detected in immunoblots of transfected HEK293 cells.
(Ea) Knockdown of Cse1l using an antisense morpholino targeting the translation start site phenocopies the baos866 mutation (22% penetrance at 5 days
postfertilization [dpf], n = 220).
(Eb) Immunoblot of 5 dpf uninjected and Cse1l morphants demonstrating knockdown of this protein.
(F) In situ hybridization analysis using an antisense probe directed against the 30 end and untranslated region of the cse1l mRNA.
(G) Immunofluorescence onWT sections showing Cse1l in the subapical (arrowhead) and basolateral (arrow) regions of intestinal cells at 120 hpf. Scale bars
represent 50 mm.
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1843agreement with the size prediction inferred from cDNA
sequencing (Figure 3Db).
Next, we knocked down the expression of Cse1l and Ptprg
using antisense morpholinos. Knockdown of Cse1l
(Figure 3Ea), but not Ptprg (data not shown), phenocopied
baos866. Immunoblot analysis confirmed that the phenotype
of the Cse1l morphants showed a good correlation with the
level of Cse1l depletion (Figure 3Eb). To determine the pattern
of cse1l expression, we performed an in situ hybridization (ISH)
analysis during WT development. The cse1l transcript was
present at the two-cell stage (Figure 3F), indicating that it is
maternally provided. Expression was broad early on but
became restricted to the endoderm and parts of the brain by
48 hpf. At 96 hpf, cse1lwas strongly expressed in the gut, liver,
exocrine pancreas, and parts of the brain and retina
(Figure 3F). Expression was strongest in the gut after 96 hpf,
coinciding with the onset of the gut expansion phenotype.
Thus, the expression pattern of cse1l shows a good correlation
with the baos866 phenotype, affecting mostly gut, liver, andpancreas. To determine the subcellular localization of the
Cse1l protein, we stained sections of 120 hpf WT larvae.
At 120 hpf, Cse1l was found enriched in the gut and liver where
we also found expression by ISH. The protein localized to the
subapical and apical region of gut enterocytes and was also
found associated with lateral and basal membranes
(Figure 3G). Altogether, our data indicate that bao corresponds
to cse1l.
Cse1l was originally isolated in a screen looking for regula-
tors of chromosome segregation (hence the name) in yeast
[17]. This highly conserved (86% identity and 93% similarity
between zebrafish and humans) and essential gene [18] has
been implicated in apoptosis [19], nuclear-cytoplasmic trans-
port [20], cell-cell adhesion [21], and chromatin regulation [22].
Therefore, it seems likely that the cell delamination/apoptosis
phenotype in baos866 mutants is linked to the nuclear and
lateral membrane functions of Cse1l. However, the role of
Cse1l in regulating CFTR-dependent fluid secretion is clearly
separable from other functions (Figure 2Ab). Moreover,
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Figure 4. Cse1l Negatively Regulates Fluid
Secretion in Mammalian MDCK-C7 Cells
(Aa) Zebrafish GFP-Cse1l, but not GFP-Cse1ls866,
coimmunoprecipitates with human CFTR-CTHA.
(Ab) Partial colocalization (arrows) of GFP-Cse1l
and CFTR-CTHA in transfected HEK293 cells.
N indicates nucleus. Scale bar represents 10 mm.
(B) Overexpression of zebrafish GFP-Cse1l abro-
gates the stimulatory effect of forskolin on CFTR-
dependent fluid secretion in 3D cultures of
mammalian MDCK-C7 cells.
(Ba) MDCK-C7 cells were grown on Matrigel for
4 days, and forskolin (1 mM) was then added for
16 hr before the cysts were fixed and imaged.
Green is GFP, red is F-actin, and blue is b-cate-
nin. Scale bars represent 50 mm.
(Bb) Quantification of data from (Ba) (n = 161 for
GFP-Cse1ls866; n = 131 for GFP-Cse1l). Error
bars indicate standard error of the mean.
(C) Depletion of Cse1l leads to increased fluid
secretion in 3D cultures of MDCK-C7 cells.
(Ca) Immunoblot showing knockdown of dog
Cse1l in cells expressing a shRNA targeting
Cse1l (Sh-4) but not in control cells expressing
a nonsilencing shRNA (Sh-scr).
(Cb) Knockdown of dog Cse1l leads to lumen
expansion in control but not in GFP-Cse1l-ex-
pressing MDCK-C7 cells in 3D cultures (5 days in Matrigel) following forskolin treatment. Red is F-actin, green is b-catenin in upper panels and GFP in lower
panels, and blue is ToPro. Scale bars represent 50 mm.
(Cc) Quantification of data from (Cb) (n = 200 for control; n = 149 for GFP-Cse1l). Error bars indicate standard error of the mean.
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1844zebrafish mutations in the nucleoporin gene elys trigger
apoptosis in the gut but not fluid accumulation [23, 24].
Our data suggest a functional interaction between Cse1l and
CFTR. To test whether these two proteins also interact physi-
cally, we performed coimmunoprecipitation experiments in
HEK293 cells expressing human HA-tagged CFTR (CFTR-
HA) [25] and GFP-Cse1l or GFP-Cse1ls866. Notably, CFTR-HA
coimmunoprecipitated with GFP-Cse1l but showed a much
weaker interaction with GFP-Cse1ls866 (Figure 4Aa). At the
immunofluorescence level, a fraction of GFP-Cse1l colocal-
ized with CFTR-HA (Figure 4Ab). We also coimmunoprecipi-
tated endogenous CFTR and Cse1l from human intestinal
Caco-2 cells (data not shown). Interestingly, a recent mass
spectrometric analysis of CFTR-associated proteins identified
CSE1L among several other potential CFTR partners in various
human cell lines [26].
To investigate whether Cse1l regulates fluid secretion in
mammalian cells, we employed a clone of Madin-Darby
canine kidney (MDCK) cells that expresses endogenous
CFTR (MDCK-C7) [27] and performed 3D cultures. When
grown in Matrigel, these cells form hollow cysts that exhibit
forskolin-stimulated, CFTR-dependent fluid transport and
lumen expansion [9, 28]. Forskolin addition increases intracel-
lular cAMP levels and stimulates protein kinase A, which in
turn activates the CFTR channel through phosphorylation
[29]. To test the effect of Cse1l overexpression and knock-
down, we generated stable MDCK-C7 lines overexpressing
GFP-tagged WT and mutant zebrafish Cse1l (GFP-Cse1l and
GFP-Cse1ls866, respectively) and examined the response to
forskolin in 3D cultures. Cse1l is highly conserved between
zebrafish and mammals, and the fish protein can functionally
substitute for the mammalian protein (see below). Interest-
ingly, although addition of forskolin (1 mM for 16 hr) led to
a robust (25% increase in diameter; close to 200% increase
in volume) and significant (p < 0.00001, n = 161) enlargement
of control (vector only) or GFP-Cse1ls866-expressing cysts, itdid not affect the size of GFP-Cse1l-expressing cysts
(p = 0.695, n = 131) (Figure 4). It is important to note that
whereas cysts from cells transfected with vector only or
GFP-Cse1ls866 possessed mostly very thin (stretched) cells
surrounding a single large lumen (100 mm on average), GFP-
Cse1l-expressing cysts were mostly multilayered and con-
tained multiple small lumens (1–10 mm). Thus, the difference
in luminal volume was in fact much greater than the 200%
increase derived from measurements of cyst diameter. Next,
we knocked down (>80%) endogenous Cse1l expression via
lentivirus-mediated expression of short hairpin interfering
RNAs (shRNAs) (Figure 4Ca). The DNA sequence differences
between zebrafish and dog Cse1l make the zebrafish
construct insensitive to the shRNAs (Figure 4Ca). Upon
Cse1l knockdown, we observed a robust (48% increase in
diameter; more than 300% increase in total cyst volume) and
significant (p < 0.00001, n = 200) expansion of the lumen
that could be blocked by GFP-Cse1l expression (p = 0.643,
n = 149). Finally, we assayed CFTR activity in HEK293 cells
expressing CFTR by using a halide-sensitive YFP variant
(YFP-H148Q) [30] and found that Cse1l overexpression
strongly inhibited CFTR activity (Figure S4). Together, these
experiments suggest that Cse1l is a negative regulator of
CFTR activity in mammalian cells.
Altogether, our results are consistent with a scenario in
which binding of Cse1l to CFTR results in the inhibition of the
channel. Alternatively, Cse1l may be required for the function
of a CFTR inhibitor. Although we cannot exclude an effect on
the activity of other channels or channel cross-regulation,
the physical interaction of Cse1l with CFTR suggests that
Cse1l regulates CFTR activity directly.
Studies of CFTR function have relied mostly on cell culture
and genetic association studies of populations of cystic
fibrosis patients. Although these studies have provided
valuable insights, an in vivo correlate has not yet been estab-
lished. This work establishes zebrafish as a forward genetics
Cse1l Controls Fluid Secretion through CFTR
1845model system to study CFTR biology and demonstrates that
these studies are translatable to mammalian models.
Supplemental Information
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at doi:10.1016/j.
cub.2010.09.012.
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